 | • レポートコード：MRC2-11QY11159 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は骨肉腫診断・治療のグローバル市場について調査・分析したレポートです。種類別（放射線療法、化学療法、凍結手術、外科的治療、標的療法）市場規模、用途別（多専門病院、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別骨肉腫診断・治療の競争状況、市場シェア ・世界の骨肉腫診断・治療市場：種類別市場規模 2015年-2020年（放射線療法、化学療法、凍結手術、外科的治療、標的療法） ・世界の骨肉腫診断・治療市場：種類別市場規模予測 2021年-2026年（放射線療法、化学療法、凍結手術、外科的治療、標的療法） ・世界の骨肉腫診断・治療市場：用途別市場規模 2015年-2020年（多専門病院、がん研究センター） ・世界の骨肉腫診断・治療市場：用途別市場規模予測 2021年-2026年（多専門病院、がん研究センター） ・北米の骨肉腫診断・治療市場分析：米国、カナダ ・ヨーロッパの骨肉腫診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの骨肉腫診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の骨肉腫診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの骨肉腫診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ablynx、Allergan、AVEO Pharmaceuticals、Amgen、Novartis、Bayer、Pfizer、Celldex Therapeutics、Debiopharm、Eli Lilly、Roche、Galapagos、Infinity Pharmaceuticals、Medivir、Merrion Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body.
Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatric population is one of the major factors that contribute to the growth of the market as several diseases rise with aging. The increase in the prevalence of the Paget diseases and others are the factors that are driving the market.
Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market
The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bone Cancer Diagnosis and Therapeutics Scope and Market Size
Bone Cancer Diagnosis and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bone Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Ablynx
Allergan
AVEO Pharmaceuticals
Amgen
Novartis
Bayer
Pfizer
Celldex Therapeutics
Debiopharm
Eli Lilly
Roche
Galapagos
Infinity Pharmaceuticals
Medivir
Merrion Pharmaceuticals
Market segment by Type, the product can be split into
Radiation therapies
Chemotherapy
Cryosurgery
Surgical treatment
Targeted therapy
Market segment by Application, split into
Multispecialty hospitals
Cancer research centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bone Cancer Diagnosis and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Bone Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiation therapies
1.4.3 Chemotherapy
1.4.4 Cryosurgery
1.4.5 Surgical treatment
1.4.6 Targeted therapy
1.5 Market by Application
1.5.1 Global Bone Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Multispecialty hospitals
1.5.3 Cancer research centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bone Cancer Diagnosis and Therapeutics Market Perspective (2015-2026)
2.2 Global Bone Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Bone Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bone Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bone Cancer Diagnosis and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Bone Cancer Diagnosis and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bone Cancer Diagnosis and Therapeutics Players by Market Size
3.1.1 Global Top Bone Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bone Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bone Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.2.1 Global Bone Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bone Cancer Diagnosis and Therapeutics Revenue in 2019
3.3 Bone Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.4 Key Players Bone Cancer Diagnosis and Therapeutics Product Solution and Service
3.5 Date of Enter into Bone Cancer Diagnosis and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bone Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
5.2 Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
6.2 Bone Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020)
6.3 North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
6.4 North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
7.2 Bone Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
8.2 Bone Cancer Diagnosis and Therapeutics Key Players in China (2019-2020)
8.3 China Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
8.4 China Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
9.2 Bone Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
10.2 Bone Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
11.2 Bone Cancer Diagnosis and Therapeutics Key Players in India (2019-2020)
11.3 India Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
11.4 India Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bone Cancer Diagnosis and Therapeutics Market Size (2015-2020)
12.2 Bone Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ablynx
13.1.1 Ablynx Company Details
13.1.2 Ablynx Business Overview
13.1.3 Ablynx Bone Cancer Diagnosis and Therapeutics Introduction
13.1.4 Ablynx Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020))
13.1.5 Ablynx Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Bone Cancer Diagnosis and Therapeutics Introduction
13.2.4 Allergan Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 AVEO Pharmaceuticals
13.3.1 AVEO Pharmaceuticals Company Details
13.3.2 AVEO Pharmaceuticals Business Overview
13.3.3 AVEO Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
13.3.4 AVEO Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.3.5 AVEO Pharmaceuticals Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Bone Cancer Diagnosis and Therapeutics Introduction
13.4.4 Amgen Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Bone Cancer Diagnosis and Therapeutics Introduction
13.5.4 Novartis Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Bone Cancer Diagnosis and Therapeutics Introduction
13.6.4 Bayer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Bone Cancer Diagnosis and Therapeutics Introduction
13.7.4 Pfizer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Celldex Therapeutics
13.8.1 Celldex Therapeutics Company Details
13.8.2 Celldex Therapeutics Business Overview
13.8.3 Celldex Therapeutics Bone Cancer Diagnosis and Therapeutics Introduction
13.8.4 Celldex Therapeutics Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.8.5 Celldex Therapeutics Recent Development
13.9 Debiopharm
13.9.1 Debiopharm Company Details
13.9.2 Debiopharm Business Overview
13.9.3 Debiopharm Bone Cancer Diagnosis and Therapeutics Introduction
13.9.4 Debiopharm Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.9.5 Debiopharm Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Bone Cancer Diagnosis and Therapeutics Introduction
13.10.4 Eli Lilly Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
13.10.5 Eli Lilly Recent Development
13.11 Roche
10.11.1 Roche Company Details
10.11.2 Roche Business Overview
10.11.3 Roche Bone Cancer Diagnosis and Therapeutics Introduction
10.11.4 Roche Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
10.11.5 Roche Recent Development
13.12 Galapagos
10.12.1 Galapagos Company Details
10.12.2 Galapagos Business Overview
10.12.3 Galapagos Bone Cancer Diagnosis and Therapeutics Introduction
10.12.4 Galapagos Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
10.12.5 Galapagos Recent Development
13.13 Infinity Pharmaceuticals
10.13.1 Infinity Pharmaceuticals Company Details
10.13.2 Infinity Pharmaceuticals Business Overview
10.13.3 Infinity Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
10.13.4 Infinity Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
10.13.5 Infinity Pharmaceuticals Recent Development
13.14 Medivir
10.14.1 Medivir Company Details
10.14.2 Medivir Business Overview
10.14.3 Medivir Bone Cancer Diagnosis and Therapeutics Introduction
10.14.4 Medivir Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
10.14.5 Medivir Recent Development
13.15 Merrion Pharmaceuticals
10.15.1 Merrion Pharmaceuticals Company Details
10.15.2 Merrion Pharmaceuticals Business Overview
10.15.3 Merrion Pharmaceuticals Bone Cancer Diagnosis and Therapeutics Introduction
10.15.4 Merrion Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020)
10.15.5 Merrion Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bone Cancer Diagnosis and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Bone Cancer Diagnosis and Therapeutics Revenue
Table 3. Ranking of Global Top Bone Cancer Diagnosis and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bone Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiation therapies
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Cryosurgery
Table 8. Key Players of Surgical treatment
Table 9. Key Players of Targeted therapy
Table 10. Global Bone Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Bone Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Bone Cancer Diagnosis and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Bone Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Bone Cancer Diagnosis and Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Bone Cancer Diagnosis and Therapeutics Players
Table 21. Global Bone Cancer Diagnosis and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Bone Cancer Diagnosis and Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Bone Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Diagnosis and Therapeutics as of 2019)
Table 24. Global Bone Cancer Diagnosis and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Bone Cancer Diagnosis and Therapeutics Product Solution and Service
Table 27. Date of Enter into Bone Cancer Diagnosis and Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Bone Cancer Diagnosis and Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Bone Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Bone Cancer Diagnosis and Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Bone Cancer Diagnosis and Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 37. North America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 39. North America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 43. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 49. China Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 51. China Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 55. Japan Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 67. India Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 69. India Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Bone Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Bone Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 73. Central & South America Bone Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Bone Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Bone Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Bone Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 77. Ablynx Company Details
Table 78. Ablynx Business Overview
Table 79. Ablynx Product
Table 80. Ablynx Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 81. Ablynx Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Product
Table 85. Allergan Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 86. Allergan Recent Development
Table 87. AVEO Pharmaceuticals Company Details
Table 88. AVEO Pharmaceuticals Business Overview
Table 89. AVEO Pharmaceuticals Product
Table 90. AVEO Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 91. AVEO Pharmaceuticals Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Product
Table 95. Amgen Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 96. Amgen Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Product
Table 105. Bayer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 106. Bayer Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Product
Table 110. Pfizer Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 111. Pfizer Recent Development
Table 112. Celldex Therapeutics Business Overview
Table 113. Celldex Therapeutics Product
Table 114. Celldex Therapeutics Company Details
Table 115. Celldex Therapeutics Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 116. Celldex Therapeutics Recent Development
Table 117. Debiopharm Company Details
Table 118. Debiopharm Business Overview
Table 119. Debiopharm Product
Table 120. Debiopharm Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 121. Debiopharm Recent Development
Table 122. Eli Lilly Company Details
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Product
Table 125. Eli Lilly Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 126. Eli Lilly Recent Development
Table 127. Roche Company Details
Table 128. Roche Business Overview
Table 129. Roche Product
Table 130. Roche Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 131. Roche Recent Development
Table 132. Galapagos Company Details
Table 133. Galapagos Business Overview
Table 134. Galapagos Product
Table 135. Galapagos Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 136. Galapagos Recent Development
Table 137. Infinity Pharmaceuticals Company Details
Table 138. Infinity Pharmaceuticals Business Overview
Table 139. Infinity Pharmaceuticals Product
Table 140. Infinity Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 141. Infinity Pharmaceuticals Recent Development
Table 142. Medivir Company Details
Table 143. Medivir Business Overview
Table 144. Medivir Product
Table 145. Medivir Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 146. Medivir Recent Development
Table 147. Merrion Pharmaceuticals Company Details
Table 148. Merrion Pharmaceuticals Business Overview
Table 149. Merrion Pharmaceuticals Product
Table 150. Merrion Pharmaceuticals Revenue in Bone Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 151. Merrion Pharmaceuticals Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Radiation therapies Features
Figure 3. Chemotherapy Features
Figure 4. Cryosurgery Features
Figure 5. Surgical treatment Features
Figure 6. Targeted therapy Features
Figure 7. Global Bone Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Multispecialty hospitals Case Studies
Figure 9. Cancer research centers Case Studies
Figure 10. Bone Cancer Diagnosis and Therapeutics Report Years Considered
Figure 11. Global Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Bone Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bone Cancer Diagnosis and Therapeutics Market Share by Players in 2019
Figure 16. Global Top Bone Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Diagnosis and Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bone Cancer Diagnosis and Therapeutics Revenue in 2019
Figure 18. North America Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bone Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…- 中咽頭がん診断・治療の世界市場（～2026年） Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor d…
- 肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
- 皮膚がん診断・治療の世界市場（～2026年） Skin cancer is the uncontrolled development of anomalous skin cells. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market Th…
- 骨転移治療薬の世界市場（～2026年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…